anti-TRAIL R2 mAb HGS-ETR2
Term · Oncology and biomedicine · MLC-T-ONC-000656
A substance being studied in the treatment of some types of cancer. It binds to a protein called TRAIL-R2 on the surface of some tumor cells, which may kill the tumor cells. Anti-TRAIL R2 mAb HGS-ETR2 is a type of monoclonal antibody. Also called HGS-ETR2 and lexatumumab.
| Identifier | MLC-T-ONC-000656 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | HGS-ETR2; lexatumumab |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-000656",
"term": "anti-TRAIL R2 mAb HGS-ETR2",
"field": "Oncology and biomedicine",
"definition": "A substance being studied in the treatment of some types of cancer. It binds to a protein called TRAIL-R2 on the surface of some tumor cells, which may kill the tumor cells. Anti-TRAIL R2 mAb HGS-ETR2 is a type of monoclonal antibody. Also called HGS-ETR2 and lexatumumab.",
"synonyms": [
"HGS-ETR2",
"lexatumumab"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/anti-trail-r2-mab-hgs-etr2/"
}
Record 2,291 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.